SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-026672
Filing Date
2022-12-16
Accepted
2022-12-16 16:10:57
Documents
13
Period of Report
2022-12-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K srne-20221215.htm   iXBRL 8-K 99721
2 EX-10.1 srne-ex10_1.htm EX-10.1 268509
  Complete submission text file 0000950170-22-026672.txt   526588

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srne-20221215_lab.xml EX-101.LAB 12806
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srne-20221215.xsd EX-101.SCH 2400
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srne-20221215_pre.xml EX-101.PRE 10417
7 EXTRACTED XBRL INSTANCE DOCUMENT srne-20221215_htm.xml XML 4520
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 221468073
SIC: 2836 Biological Products, (No Diagnostic Substances)